Iradimed (IRMD) Current Assets (2013 - 2026)

Iradimed (IRMD) has 14 years of Current Assets data on file, last reported at $86.4 million in Q1 2026.

• Current Assets for Q1 2026 came in at $86.4 million, up 15.02% year-over-year; the trailing twelve-month figure through Mar 2026 was $86.4 million (up 15.02% YoY), and the FY2025 annual result was $81.2 million, up 7.92% from the prior year.
• Current Assets improved to $86.4 million in Q1 2026 per IRMD's latest filing, from $81.2 million in the prior quarter.
• Over five years, Current Assets peaked at $86.4 million in Q1 2026 and troughed at $61.3 million in Q1 2023.
• A 5-year average of $74.0 million and a median of $74.3 million in 2024 frame the typical range for Current Assets.
• The sharpest annual moves came in 2023 and 2024: Current Assets decreased 6.44% in 2023, then increased 17.27% in 2024.
• A 5-year view of Current Assets shows it stood at $77.5 million in 2022, then declined by 1.92% to $76.0 million in 2023, then slipped by 1.0% to $75.2 million in 2024, then grew by 7.92% to $81.2 million in 2025, then gained by 6.43% to $86.4 million in 2026.
• Business Quant data shows IRMD's Current Assets at $86.4 million in Q1 2026, $81.2 million in Q4 2025, and $84.9 million in Q3 2025.